Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04534127 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jan 1, 2026 to Jan 1, 2027
    • Study completion date: Jan 1, 2026 to Jul 1, 2027
    v9
  2. Primary completion date: Jan 1, 2025 to Jan 1, 2026v8
  3. Re-verified, no change to tracked fieldsv7
  4. Primary completion date: Jan 1, 2024 to Jan 1, 2025v6
  5. 2 versions Re-verified since Jun 14, 2022, no change to tracked fieldsv4-v5
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Jan 1, 2023 to Jan 1, 2024
    • Study completion date: Jan 1, 2025 to Jan 1, 2026
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 1, 2020 to Dec 22, 2020
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia
Trial Details
NCT Number NCT04534127
Lead Sponsor Alpha Tau Medical LTD.
Conditions
(from sponsor)		 Skin Cancer, Mucosal Neoplasm of Oral Cavity, Soft Tissue Neoplasm
Related terms Basal Cell Carcinoma, Carcinoma, Squamous Cell, Lip Neoplasms, Sarcoma, Kaposi, Skin Neoplasms, Soft Tissue Neoplasms, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms
Enrollment 56 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov